First peripheral drug-eluting stent clinical results from China: 1-year outcomes of the Zilver PTX China study

PURPOSE: The benefit of using the Zilver PTX drug-eluting stent (DES) in superficial femoral artery (SFA) lesions has been demonstrated in multiple clinical studies. This prospective, multicenter study evaluated the 1-year safety and effectiveness of the DES for the treatment of femoropopliteal lesi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Wei, Böhme, Tanja, Fu, Weiguo, Liu, Changwei, Zhang, Xiaoming, Liu, Peng, Zhang, Jiwei, Zou, Yinghua, Lu, Xinwu, Lottes, Aaron E., O'Leary, Erin E., Zeller, Thomas, Dake, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551216/
https://www.ncbi.nlm.nih.gov/pubmed/36237908
http://dx.doi.org/10.3389/fcvm.2022.877578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551216/
https://www.ncbi.nlm.nih.gov/pubmed/36237908
http://dx.doi.org/10.3389/fcvm.2022.877578

Ejemplares similares